Judith Hagenbuchner - Concepedia

Author

Judith Hagenbuchner

Innsbruck Medical University ORCID

Also Known As

J Hagenbuchner, Judith Hagenbuchner, Judith Hagenbuchner Markus Holzner

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Innsbruck Medical University Tyrolean Cancer Research Institute Universität Innsbruck University Medical Center Freiburg University of Alberta

About

Judith Hagenbuchner is an author at Innsbruck Medical University specializing in medicine, cell biology, and oxidative stress.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	880
2	Biochemistry	5	5	369
3	Health Sciences	3	3	120
4	Engineering	2	2	87
5	Natural Sciences	2	2	293

Judith Hagenbuchner

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
FOXO3-induced reactive oxygen species are regulated by BCL2L11 (Bim) and SESN3 Judith Hagenbuchner, Andrey Kuznetsov, Martin Hermann, Journal of Cell Science Redox SignalingTranscriptional RegulationSignal TransductionRedox RegulatorCell Signaling	2012	186
BIRC5/Survivin enhances aerobic glycolysis and drug resistance by altered regulation of the mitochondrial fusion/fission machinery Judith Hagenbuchner, Andrey Kuznetsov, Petra Obexer, Oncogene BiochemistryMitochondrial FunctionAerobic GlycolysisMedicineNatural Sciences	2012	181
Mitochondria and FOXO3: breath or die Judith Hagenbuchner, Michael J. Ausserlechner Frontiers in Physiology Cell DeathMitochondrial BiologyCell Death MechanismsRedox BiologyTumor Biology	2013	112
BIRC5/Survivin as a target for glycolysis inhibition in high-stage neuroblastoma Judith Hagenbuchner, Ursula Kiechl‐Kohlendorfer, Petra Obexer, Oncogene Tumor BiologyMedicinePharmacologyTumor TargetingAnti-cancer Agent	2015	93
Repression of BIRC5/Survivin by FOXO3/FKHRL1 Sensitizes Human Neuroblastoma Cells to DNA Damage-induced Apoptosis Petra Obexer, Judith Hagenbuchner, Thomas Unterkircher, Molecular Biology of the Cell Chemoprevention StrategyApoptosisCell DeathGliomaTumor Biology	2009	74
A drug library screen identifies Carbenoxolone as novel FOXO inhibitor that overcomes FOXO3-mediated chemoprotection in high-stage neuroblastoma Stefan Salcher, Gilles A. Spoden, Judith Hagenbuchner, Oncogene	2019	71
The Anti-apoptotic Protein BCL2L1/Bcl-xL Is Neutralized by Pro-apoptotic PMAIP1/Noxa in Neuroblastoma, Thereby Determining Bortezomib Sensitivity Independent of Prosurvival MCL1 Expression Judith Hagenbuchner, Michael J. Ausserlechner, Verena Porto, Journal of Biological Chemistry	2010	69
3D bioprinted, vascularized neuroblastoma tumor environment in fluidic chip devices for precision medicine drug testing Daniel Nothdurfter, Christian Ploner, Débora C. Coraça‐Huber, Biofabrication Tissue EngineeringEngineeringEndothelial CellsFluidic Chip DevicesBiological Microenvironments	2022	67
C10ORF10/DEPP, a transcriptional target of FOXO3, regulates ROS-sensitivity in human neuroblastoma Stefan Salcher, Judith Hagenbuchner, Kathrin Geiger, Molecular Cancer	2014	56
Nuclear FOXO3 predicts adverse clinical outcome and promotes tumor angiogenesis in neuroblastoma Judith Hagenbuchner, Martina Rupp, Christina Salvador, Oncotarget Tumor BiologyMedicineTumor GrowthCellular LocalizationNuclear Foxo3	2016	37

Page 1